{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T19:53:19Z","timestamp":1774468399602,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annalsofvascularsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.avsg.2020.01.017","type":"journal-article","created":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T11:50:22Z","timestamp":1578657022000},"page":"293-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Ultrasound Aspects and Recanalization Rates in Patients with Lower-Limb Deep Venous Thrombosis Treated with Rivaroxaban"],"prefix":"10.1016","volume":"67","author":[{"given":"Rafael","family":"de Athayde Soares","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo Fernando","family":"Matielo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Cardoso","family":"Brochado Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rog\u00e9rio Duque","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Sacilotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2020.01.017_bib1","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"Bauersachs","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.avsg.2020.01.017_bib2","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1113572","article-title":"Oral rivaroxaban for the treatment of symptomatic pulmonary embolism","volume":"366","author":"Buller","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.avsg.2020.01.017_bib3","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1055\/s-0038-1666859","article-title":"Predicting post-thrombotic syndrome with ultrasonographic follow-up after deep vein thrombosis: a systematic review and meta-analysis","volume":"118","author":"Dronkers","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.avsg.2020.01.017_bib4","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jvir.2017.03.031","article-title":"Insufficient recanalization of thrombotic venous occlusion\u2014risk for postthrombotic syndrome","volume":"28","author":"Jeraj","year":"2017","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.avsg.2020.01.017_bib5","first-page":"1","article-title":"Duplex ultrasound, clinical score, thrombotic risk, and D-dimer testing for evidence based diagnosis and management of deep vein thrombosis and alternative diagnoses in the primary care setting and outpatient ward","volume":"33","author":"Michiels","year":"2014","journal-title":"Int Angiol"},{"key":"10.1016\/j.avsg.2020.01.017_bib6","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000000130","article-title":"The post-thrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association","volume":"130","author":"Kahn","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2020.01.017_bib7","doi-asserted-by":"crossref","first-page":"e42269","DOI":"10.1371\/journal.pone.0042269","article-title":"Benchmark for time in therapeutic range in venous thromboembolism: a systematic review and meta-analysis","volume":"7","author":"Erkens","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.avsg.2020.01.017_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/gtmb.2017.0152","article-title":"CYP3A activity and rivaroxaban serum concentrations in Russian patients with deep vein thrombosis","volume":"22","author":"Sychev","year":"2018","journal-title":"Genest Test Mol Biomarkers"},{"key":"10.1016\/j.avsg.2020.01.017_bib9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s10016-004-0133-3","article-title":"Comparing short-term outcomes of femoral-popliteal and iliofemoral deep venous thrombosis: early lysis and development of reflux","volume":"19","author":"Singh","year":"2005","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.avsg.2020.01.017_bib10","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0741-5214(98)70057-6","article-title":"Determinants of chronic venous disease after acute deep venous thrombosis","volume":"28","author":"Meissner","year":"1998","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2020.01.017_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.23736\/S0392-9590.18.04031-2","article-title":"Treatment of DVT with rivaroxaban and its potential to prevent the post-thrombotic syndrome","volume":"38","author":"Antignani","year":"2019","journal-title":"Int Angiol"},{"key":"10.1016\/j.avsg.2020.01.017_bib12","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.surg.2019.05.030","article-title":"Comparison of the recanalization rate and postthrombotic syndrome in patients with deep venous thrombosis treated with rivaroxaban or warfarin","volume":"166","author":"de Athayde Soares","year":"2019","journal-title":"Surgery"},{"key":"10.1016\/j.avsg.2020.01.017_bib13","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1016\/j.thromres.2012.11.029","article-title":"Whole blood clots are more resistant to lysis than plasma clots\u2014greater efficacy of rivaroxaban","volume":"131","author":"Varin","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.avsg.2020.01.017_bib14","first-page":"1","article-title":"Antithrombotic medications and their impact on fibrin clot structure and function","volume":"69","author":"Undas","year":"2018","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.avsg.2020.01.017_bib15","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMoa1615066","article-title":"Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis","volume":"377","author":"Vedantham","year":"2017","journal-title":"N Engl J Med"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509620300376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509620300376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:57:17Z","timestamp":1760187437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509620300376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":15,"alternative-id":["S0890509620300376"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2020.01.017","relation":{},"ISSN":["0890-5096"],"issn-type":[{"value":"0890-5096","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ultrasound Aspects and Recanalization Rates in Patients with Lower-Limb Deep Venous Thrombosis Treated with Rivaroxaban","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2020.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}